山西泽辰医药科技

Shanxi Zechen Pharmaceutical Technology is a Chinese biotechnology company focused on the discovery and development of innovative small molecule therapeutics. Headquartered in Taiyuan, the company specializes in therapeutic areas including oncology, cardiovascular diseases, and cerebrovascular conditions. Its business model integrates proprietary drug R&D with technical services, such as chemical process optimization and the production of high-end pharmaceutical intermediates. Shanxi Zechen operates in close coordination with its research affiliates to bridge the gap between laboratory-scale synthesis and industrial manufacturing. The company aims to provide high-quality active pharmaceutical ingredients (APIs) and novel drug candidates to the global healthcare market.